These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1369 related articles for article (PubMed ID: 23024028)

  • 1. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.
    Khanna D; Fitzgerald JD; Khanna PP; Bae S; Singh MK; Neogi T; Pillinger MH; Merill J; Lee S; Prakash S; Kaldas M; Gogia M; Perez-Ruiz F; Taylor W; Lioté F; Choi H; Singh JA; Dalbeth N; Kaplan S; Niyyar V; Jones D; Yarows SA; Roessler B; Kerr G; King C; Levy G; Furst DE; Edwards NL; Mandell B; Schumacher HR; Robbins M; Wenger N; Terkeltaub R;
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1431-46. PubMed ID: 23024028
    [No Abstract]   [Full Text] [Related]  

  • 2. An appraisal of the 2012 American College of Rheumatology Guidelines for the Management of Gout.
    Nuki G
    Curr Opin Rheumatol; 2014 Mar; 26(2):152-61. PubMed ID: 24492863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Austrian 3e-recommendations for diagnosis and management of gout 2013].
    Sautner J; Gruber J; Herold M; Zwerina J; Leeb BF
    Wien Klin Wochenschr; 2014 Feb; 126(3-4):79-89. PubMed ID: 24297266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term management of gout: nonpharmacologic and pharmacologic therapies.
    Chaichian Y; Chohan S; Becker MA
    Rheum Dis Clin North Am; 2014 May; 40(2):357-74. PubMed ID: 24703352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).
    Dalbeth N; Bardin T; Doherty M; Lioté F; Richette P; Saag KG; So AK; Stamp LK; Choi HK; Terkeltaub R
    Nat Rev Rheumatol; 2017 Sep; 13(9):561-568. PubMed ID: 28794514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hyperuricaemia and gout.
    Roddy E; Doherty M
    Clin Med (Lond); 2013 Aug; 13(4):400-3. PubMed ID: 23908515
    [No Abstract]   [Full Text] [Related]  

  • 7. Gout Study Group: update on hyperuricemia and gout.
    Terkeltaub R; Zelman D; Scavulli J; Perez-Ruiz F; Lioté F
    Joint Bone Spine; 2009 Jul; 76(4):444-6. PubMed ID: 19559637
    [No Abstract]   [Full Text] [Related]  

  • 8. New therapeutic approach to hyperuricemia and gout in the light of recommendations.
    Lioté F
    Joint Bone Spine; 2016 Jul; 83(4):376-80. PubMed ID: 27085801
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of treatment of hyperuricemic in patients admitted to the rheumatology ward and evaluation of compliance with the 2012 ACR Guidelines.
    Banse C; Fardellone P; Paccou J
    Joint Bone Spine; 2014 Oct; 81(5):461-2. PubMed ID: 24703403
    [No Abstract]   [Full Text] [Related]  

  • 10. New developments in gout.
    Harrold L
    Curr Opin Rheumatol; 2013 May; 25(3):304-9. PubMed ID: 23466959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The British Society for Rheumatology Guideline for the Management of Gout.
    Hui M; Carr A; Cameron S; Davenport G; Doherty M; Forrester H; Jenkins W; Jordan KM; Mallen CD; McDonald TM; Nuki G; Pywell A; Zhang W; Roddy E;
    Rheumatology (Oxford); 2017 Jul; 56(7):e1-e20. PubMed ID: 28549177
    [No Abstract]   [Full Text] [Related]  

  • 12. Are hyperuricemia and gout different diseases? Comment on the guidelines for the diagnosis and management of hyperuricemia and gout with the healthcare professional perspectives in China.
    Li Y; Lin Z; Wang Y; Wu H; Zhang B
    Int J Rheum Dis; 2023 Sep; 26(9):1866-1868. PubMed ID: 36719050
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic approaches in the treatment of gout.
    Pillinger MH; Mandell BF
    Semin Arthritis Rheum; 2020 Jun; 50(3S):S24-S30. PubMed ID: 32620199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hyperuricemia and gout].
    Gröbner W; Walter-Sack I
    Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements.
    Li Q; Li X; Wang J; Liu H; Kwong JS; Chen H; Li L; Chung SC; Shah A; Chen Y; An Z; Sun X; Hemingway H; Tian H; Li S
    BMJ Open; 2019 Aug; 9(8):e026677. PubMed ID: 31446403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge and practice in the management of asymptomatic hyperuricemia among primary health care physicians in Jeddah, Western Region of Saudi Arabia.
    Alqarni NA; Hassan AH
    Saudi Med J; 2018 Dec; 39(12):1218-1225. PubMed ID: 30520504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hyperuricemia and gout based on the guideline for the management of hyperuricemia and gout].
    Taniguchi A
    Nihon Yakurigaku Zasshi; 2010 Dec; 136(6):330-4. PubMed ID: 21139283
    [No Abstract]   [Full Text] [Related]  

  • 19. [The management of gout].
    Peters C; Malaise O; Longton J; André B; Ribbens C
    Rev Med Liege; 2023 Dec; 78(12):733-739. PubMed ID: 38095039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S
    Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.